SCOPUS 정보 검색 플랫폼

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 3, 2012, Pages 1666-

Pharmacokinetic mismatch of tuberculosis drugs

(1) Peloquin, Charles A a

a UNIVERSITY OF FLORIDA (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFABUTIN; RIFAMPICIN; RIFAMYCIN; RIFAPENTINE; TUBERCULOSTATIC AGENT;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; DRUG HALF LIFE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LETTER; MIXED INFECTION; MYCOBACTERIUM TUBERCULOSIS; PHARMACOKINETICS; PRIORITY JOURNAL; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; HUMANS; ISONIAZID; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84857169056 PISSN: 00664804 EISSN: 10986596 Source Type: Journal
DOI: 10.1128/AAC.06303-11 Document Type: Letter

Times cited : (3)

References (9)

1
- 34547620711
- Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears
- DOI 10.1128/AAC.01474-06
- Diacon AH, et al. 2007. Early bactericidal activity of high-dose rifampin in patients with pulmonary tuberculosis evidenced by positive sputum smears. Antimicrob. Agents Chemother. 51:2994-2996. (Pubitemid 47206244)
- (2007) Antimicrobial Agents and Chemotherapy , vol.51 , Issue.8 , pp. 2994-2996
- Diacon, A.H.¹ Patientia, R.F.² Venter, A.³ Van Helden, P.D.⁴ Smith, P.J.⁵ McIlleron, H.⁶ Maritz, J.S.⁷ Donald, P.R.⁸

2
- 0019486287
- Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis
- Dickinson JM, Mitchison DA. 1981. Experimental models to explain thehigh sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am. Rev. Respir. Dis. 123:367-371. (Pubitemid 11105700)
- (1981) American Review of Respiratory Disease , vol.123 , Issue.4 , pp. 367-371
- Dickinson, J.M.¹ Mitchison, D.A.²

3
- 72849124759
- Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis
- Boulanger C, et al. 2009. Pharmacokinetic evaluation of rifabutin in combination with lopinavir-ritonavir in patients with HIV infection and active tuberculosis. Clin. Infect. Dis. 49:1305-1311.
- (2009) Clin. Infect. Dis. , vol.49 , pp. 1305-1311
- Boulanger, C.¹

4
- 32144435415
- Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis
- DOI 10.1164/rccm.200503-417OC
- Burman W, et al. 2006. Tuberculosis Trials Consortium. Acquired rifamycin resistance with twice-weekly treatment of HIV-related tuberculosis. Am. J. Respir. Crit. Care Med. 173:350-356. (Pubitemid 43209091)
- (2006) American Journal of Respiratory and Critical Care Medicine , vol.173 , Issue.3 , pp. 350-356
- Burman, W.¹ Benator, D.² Vernon, A.³ Khan, A.⁴ Jones, B.⁵ Silva, C.⁶ Lahart, C.⁷ Weis, S.⁸ King, B.⁹ Mangura, B.¹⁰ Weiner, M.¹¹ El-Sadr, W.¹²

5
- 0038628994
- Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days
- DOI 10.1164/rccm.200210-1125OC
- Jindani A, Doré CJ, Mitchison DA. 2003. Bactericidal and sterilizing activities of antituberculosis drugs during the first 14 days. Am. J. Respir. Crit. Care Med. 167:1348-1354. (Pubitemid 36609718)
- (2003) American Journal of Respiratory and Critical Care Medicine , vol.167 , Issue.10 , pp. 1348-1354
- Jindani, A.¹ Dore, C.J.² Mitchison, D.A.³

6
- 80054715588
- Pharmacokinetic mismatch does not lead to emergence of isoniazid- Or rifampinresistant Mycobacterium tuberculosis but to better antimicrobial effect: A new paradigm for antituberculosis drug scheduling
- Srivastava S, Sherman C, Meek C, Leff R, Gumbo T. 2011. Pharmacokinetic mismatch does not lead to emergence of isoniazid- or rifampinresistant Mycobacterium tuberculosis but to better antimicrobial effect: a new paradigm for antituberculosis drug scheduling. Antimicrob. Agents Chemother. 55:5085-5089.
- (2011) Antimicrob. Agents Chemother. , vol.55 , pp. 5085-5089
- Srivastava, S.¹ Sherman, C.² Meek, C.³ Leff, R.⁴ Gumbo, T.⁵

7
- 0033614603
- Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid
- DOI 10.1016/S0140-6736(98)11467-8
- Vernon A, Burman W, Benator D, Khan A, Bozeman L. 1999. Tuberculosis Trials Consortium. Acquired rifamycin monoresistance in patients with HIV-related tuberculosis treated with once-weekly rifapentine and isoniazid. Lancet 353:1843-1847. (Pubitemid 29251017)
- (1999) Lancet , vol.353 , Issue.9167 , pp. 1843-1847
- Vernon, A.¹ Burman, W.² Benator, D.³ Khan, A.⁴ Bozeman, L.⁵

8
- 0037614780
- Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine
- DOI 10.1164/rccm.200208-951OC
- Weiner M, et al. 2003. Tuberculosis Trials Consortium. Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine. Am. J. Respir. Crit. Care Med. 167:1341-1347. (Pubitemid 36609717)
- (2003) American Journal of Respiratory and Critical Care Medicine , vol.167 , Issue.10 , pp. 1341-1347
- Weiner, M.¹ Burman, W.² Vernon, A.³ Benator, D.⁴ Peloquin, C.A.⁵ Khan, A.⁶ Weis, S.⁷ King, B.⁸ Shah, N.⁹ Hodge, T.¹⁰

9
- 20944440618
- Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis
- DOI 10.1086/429321
- Weiner M, et al. 2005. Tuberculosis Trials Consortium. Association between acquired rifamycin resistance and the pharmacokinetics of rifabutin and isoniazid among patients with HIV and tuberculosis. Clin. Infect. Dis. 40:1481-1491. (Pubitemid 40628637)
- (2005) Clinical Infectious Diseases , vol.40 , Issue.10 , pp. 1481-1491
- Weiner, M.¹ Benator, D.² Burman, W.³ Peloquin, C.A.⁴ Khan, A.⁵ Vernon, A.⁶ Jones, B.⁷ Silva-Trigo, C.⁸ Zhao, Z.⁹ Hodge, T.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.